Ophthalmic Business News

CORD has submitted a premarket approval application to the FDA for the Model SC9 IOL to treat patients with cataracts, according to a press release.

The FDA granted de novo classification to the SeCore CDx HLA Sequencing System for use as a companion diagnostic with Kimmtrak for metastatic or unresectable uveal melanoma, according to a Thermo Fisher Scientific press release.

On Friday, Dec. 2, 2022, the government snuck out an FAQ delaying implementation of the requirement that good faith estimates under the No Surprises Act must include information from co-providers.

Re-Vana Therapeutics closed a Series A round with $11.9 million in funding, an oversubscription of $4 million, according to a press release.

Gotta admit, didn’t see this coming at all.

Harrow and iOR Partners have expanded their national product supply agreement, according to a press release.

Genentech has launched a phase 2a clinical study of RG6501 for the treatment of geographic atrophy secondary to age-related macular degeneration, according to a press release from Lineage Cell Therapeutics.

Practices may find this short primer on state pass-through entity election and year-end tax tips helpful to determine whether they can benefit from a state tax strategy or create some tax savings before Jan. 1, 2023.

NEW YORK — In this Healio Video Perspective from OSN New York, John A. Hovanesian, MD, FACS, discusses Healio’s Eyeluminaries podcast, which features conversations with visionaries and newsmakers across the eye care community.

NEW YORK — In this Healio Video Perspective from OSN New York, John B. Pinto discusses the macroeconomic issues that are currently affecting ophthalmology and provides insight on what changes the future of the profession may hold.